Antibiotic therapy and outcome from immune-checkpoint inhibitors

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Abstract Sensitivity to immune checkpoint inhibitor (ICPI) therapy is governed by a complex interplay of tumor and host-related determinants. Epidemiological studies have highlighted that exposure to antibiotic therapy influences the probability of response to ICPI and predict for shorter patient su...

Full description

Bibliographic Details
Main Authors: David J. Pinato, Daria Gramenitskaya, Daniel M. Altmann, Rosemary J. Boyton, Benjamin H. Mullish, Julian R. Marchesi, Mark Bower
Format: Article
Language:English
Published: BMJ Publishing Group 2019-11-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Antibiotics
Immune checkpoint inhibitors
Survival
Online Access:http://link.springer.com/article/10.1186/s40425-019-0775-x

Internet

http://link.springer.com/article/10.1186/s40425-019-0775-x

Similar Items